CD44 Is a Negative Cell Surface Marker for Pluripotent Stem Cell Identification during Human Fibroblast Reprogramming
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD44 Is a Negative Cell Surface Marker for Pluripotent Stem Cell Identification during Human Fibroblast Reprogramming
Authors
Keywords
-
Journal
PLoS One
Volume 9, Issue 1, Pages e85419
Publisher
Public Library of Science (PLoS)
Online
2014-01-10
DOI
10.1371/journal.pone.0085419
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- High-resolution analysis with novel cell-surface markers identifies routes to iPS cells
- (2013) James O’Malley et al. NATURE
- Reprogramming human fibroblasts to pluripotency using modified mRNA
- (2013) Pankaj K Mandal et al. Nature Protocols
- Improved Methods for Reprogramming Human Dermal Fibroblasts Using Fluorescence Activated Cell Sorting
- (2013) David J. Kahler et al. PLoS One
- A Molecular Roadmap of Reprogramming Somatic Cells into iPS Cells
- (2012) Jose M. Polo et al. CELL
- Single-Cell Expression Analyses during Cellular Reprogramming Reveal an Early Stochastic and a Late Hierarchic Phase
- (2012) Yosef Buganim et al. CELL
- A Late Transition in Somatic Cell Reprogramming Requires Regulators Distinct from the Pluripotency Network
- (2012) Azadeh Golipour et al. Cell Stem Cell
- The promise of induced pluripotent stem cells in research and therapy
- (2012) Daisy A. Robinton et al. NATURE
- H3K9 methylation is a barrier during somatic cell reprogramming into iPSCs
- (2012) Jiekai Chen et al. NATURE GENETICS
- Novel Live Alkaline Phosphatase Substrate for Identification of Pluripotent Stem Cells
- (2012) Upinder Singh et al. Stem Cell Reviews and Reports
- CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression
- (2011) Rhonda L. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- A functionally characterized test set of human induced pluripotent stem cells
- (2011) Gabriella L Boulting et al. NATURE BIOTECHNOLOGY
- A bioinformatic assay for pluripotency in human cells
- (2011) Franz-Josef Müller et al. NATURE METHODS
- Methods for making induced pluripotent stem cells: reprogramming à la carte
- (2011) Federico González et al. NATURE REVIEWS GENETICS
- Lin28: A MicroRNA Regulator with a Macro Role
- (2010) Srinivas R. Viswanathan et al. CELL
- Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming
- (2010) Payman Samavarchi-Tehrani et al. Cell Stem Cell
- Defining the transcriptome and proteome in three functionally different human cell lines
- (2010) Emma Lundberg et al. Molecular Systems Biology
- Derivation of Induced Pluripotent Stem Cells from Human Peripheral Blood T Lymphocytes
- (2010) Matthew E. Brown et al. PLoS One
- Role of the Murine Reprogramming Factors in the Induction of Pluripotency
- (2009) Rupa Sridharan et al. CELL
- Live cell imaging distinguishes bona fide human iPS cells from partially reprogrammed cells
- (2009) Elayne M Chan et al. NATURE BIOTECHNOLOGY
- Efficient induction of transgene-free human pluripotent stem cells using a vector based on Sendai virus, an RNA virus that does not integrate into the host genome
- (2009) Noemi FUSAKI et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Human Induced Pluripotent Stem Cells Free of Vector and Transgene Sequences
- (2009) J. Yu et al. SCIENCE
- Dissecting direct reprogramming through integrative genomic analysis
- (2008) Tarjei S. Mikkelsen et al. NATURE
- Alkaline Phosphatase-Positive Colony Formation Is a Sensitive, Specific, and Quantitative Indicator of Undifferentiated Human Embryonic Stem Cells
- (2008) Michael D. O'Connor et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started